Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compounded incretins in clinical practice: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy.

Diabetes & metabolic syndrome·2025
Same author

Prescribing Patterns for the Treatment of Bipolar Disorder in Pregnancy: A Retrospective Cohort Study.

Journal of clinical medicine·2025
Same author

Feasibility of home blood pressure screening in the paediatric outpatient clinic setting.

Archives of disease in childhood·2025
Same author

Conception of a Personalized Medication Adherence Discharge Kit for Rivaroxaban.

Hospital pharmacy·2024
Same author

Anti-CD3 monoclonal antibodies for the prevention and treatment of type 1 diabetes: A literature review.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2022
Same author

Ibrexafungerp in the Treatment of Vulvovaginal Candidiasis.

The Annals of pharmacotherapy·2022

Related Experiment Video

Updated: Jun 7, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Nicotine replacement therapy effect on pregnancy outcomes.

Alicia B Forinash1, Jamie M Pitlick, Kylie Clark

  • 1Department of Pharmacy Practice, St. Louis College of Pharmacy, MO, USA. aforinash@stlcop.edu

The Annals of Pharmacotherapy
|October 28, 2010
PubMed
Summary

Nicotine replacement therapy (NRT) in pregnancy is recommended if behavior modification fails, as it reduces risks of preterm delivery and low birth weight compared to continued smoking. NRT does not appear to increase malformation risks.

More Related Videos

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

Related Experiment Videos

Last Updated: Jun 7, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology
  • Public Health

Background:

  • Smoking during pregnancy poses significant risks to both maternal and fetal health.
  • Behavior modification is the primary recommended treatment for smoking cessation in pregnant individuals.
  • Nicotine replacement therapy (NRT) is a potential alternative when behavioral interventions are insufficient.

Purpose of the Study:

  • To review existing data on the effects of nicotine replacement therapy (NRT) during pregnancy.
  • To assess the impact of NRT on fetal, neonatal, and maternal outcomes.
  • To evaluate the safety and efficacy of NRT for smoking cessation in pregnant populations.

Main Methods:

  • A comprehensive literature search was conducted using PubMed and the Cochrane Database.
  • Studies published in English, including human subjects, were evaluated.
  • Data on pregnancy outcomes and malformation rates associated with NRT use were analyzed.

Main Results:

  • NRT use was associated with a significant decrease in the risk of preterm delivery and low birth weight compared to continued smoking.
  • One study indicated a potential increased risk for any fetal malformation with NRT, but without adjustments for confounding factors.
  • No increased risk for major or musculoskeletal malformations was observed.

Conclusions:

  • Behavior modification therapy is the first-line approach for smoking cessation in pregnancy.
  • NRT should be considered when behavioral therapies are unsuccessful, offering benefits over continued smoking.
  • Current evidence suggests NRT does not significantly increase the risk of malformations in pregnancy.